The expression level of integrin subunit beta 3 (ITGB3) tends to increase in tumor tissues, and HCC patients with high expression of ITGB3 also have poor overall survival (no statistical significance), which may be related to the limited sample size of the TCGA database. This evidence concerns the gene ITGB3 and hepatocellular carcinoma.